Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Second G8 Central Bank Test Program

13 Jan 2014 07:00

RNS Number : 4338X
Spectra Systems Corporation
13 January 2014
Β 

ο»Ώ

Spectra Systems Corporation ("Spectra Systems" or the "Company")

Β 

Second G 8 central bank test program for supercritical fluid cleaning of banknotes

Β 

The Board is delighted to announce that Spectra Systems has agreed to enter into a testing program scheduled to begin in April of this year, with a second G 8 central bank to evaluate its supercritical CO2 ("SCCO2") technology involving the use of supercritical fluids to clean heavily soiled banknotes, thereby allowing them to be returned to circulation and effectively increasing their life. This follows the ongoing trial with the first G8 central bank announced on 25 November 2013.

With banknote replacement costs approaching $10 billion annually, and most banknotes being replaced due to soiling, data from these central bank testing programs will be invaluable to the Company for determining the potential of this technology for creating a sizable revenue steam if adopted by major central banks. Spectra Systems will provide data to the industry from these trials at the Banknote 2014 conference in Washington DC commencing on 7 April 2014.

Spectra Systems also announces that its seminal work on the cleaning of soiled banknotes using SCCO2 has been published in the prestigious peer reviewed journal of the American Chemical Society, Industrial and Chemical Engineering Research. The paper, entitled "Supercritical Fluid Cleaning of Banknotes", is authored by Nabil M. Lawandy and Andrei Y. Smuk, Spectra's CEO and Director of Research and Development, respectively. The American Chemical Society has chosen to highlight this work in a featured press release http://www.acs.org/content/acs/en/pressroom.html) which has received broad coverage, including the Los Angeles Times (http://touch.latimes.com/#section/-1/article/p2p-78822882/) and other international news bureaus (see News section on the Company website: http://www.spectra-science.com/company-news.html)

Β 

Nabil Lawandy, Spectra System's CEO, stated:

"Spectra Systems is founded on cutting edge technology and the publication of our work in a leading scientific journal provides third party validation for its breakthrough technical results. The addition of a second G 8 central bank to the testing program will provide more data to help us formulate a compelling business proposition to the industry"

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBMMFTMBIBBBI
Date   Source Headline
30th Jan 20147:00 amRNSTrading Update
16th Jan 20147:00 amRNSFirst Commercial Orders for Manufacturing Facility
13th Jan 20147:00 amRNSExtension of InkSure Asset Purchase Agreement
13th Jan 20147:00 amRNSSecond G8 Central Bank Test Program
19th Nov 20137:00 amRNSJudgment Reducing Potential Lawsuit Exposure
14th Nov 20137:00 amRNSApproval to deliver suite of sensors worth $8m
2nd Oct 20137:00 amRNSAcquisition of Assets from InkSure Technologies
1st Oct 20137:00 amRNSResult of AGM
27th Sep 20137:00 amRNSInterim Results
27th Aug 20137:00 amRNSNotice of AGM
30th Jul 20137:00 amRNSLarge Order from Central Bank
28th Jun 20137:00 amRNSPosting of Annual Report
2nd Apr 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSRemoval of Restrictions from Common Stock
18th Feb 20137:00 amRNSPre-Close Trading Update
18th Dec 20127:00 amRNSRemoval of Restrictions From Common Stock
17th Dec 20127:00 amRNSAGM Postponement
28th Nov 20127:00 amRNSNotice of AGM
28th Nov 20127:00 amRNSDirector Shareholding
27th Nov 20127:00 amRNSRemoval of Restictions From Common Stock
13th Nov 20127:00 amRNSRemoval of Restrictions From Common Stock
1st Nov 20127:00 amRNSDirector Shareholding
31st Oct 20127:00 amRNSDirector Shareholding
23rd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
16th Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
2nd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
28th Sep 20127:00 amRNSInterim results for the 6 months ended 30 Jun 2012
27th Sep 20127:00 amRNSNew Contract Agreement
18th Sep 20127:00 amRNSRemoval of Restrictions From Common Stock
31st Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
29th Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
21st Aug 20127:00 amRNSRemoval of Restrictions from Common Stock
13th Aug 20124:27 pmRNSRemoval of Restrictions From Common Stock
26th Jul 20127:00 amRNSShareholder Circular Posted
11th Jul 20127:00 amRNSDepositary Interest Facility & Admission to CREST
29th Jun 20124:17 pmRNSAnnual Financial Report
25th Jun 20127:00 amRNSStatement re share price movement
6th Jun 20127:00 amRNSAcquisition
19th Apr 20127:00 amRNSFinal Results
10th Apr 20127:00 amRNSNotice of Results
14th Feb 20127:00 amRNSDirectorate Change
10th Feb 20127:00 amRNSDirectorate Change
30th Sep 20117:00 amRNSInterim Results for the 6 months ended 30 Jun 2011
4th Aug 20117:00 amRNSShareholder Notifications
1st Aug 20117:00 amRNSShareholder Notifications
25th Jul 20117:00 amRNSFirst Day of Dealings on AIM
30th Apr 20097:51 amRNSNet Asset Value(s)
29th Apr 20097:41 amRNSNet Asset Value(s)
28th Apr 20097:48 amRNSNet Asset Value(s)
27th Apr 20098:04 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.